| Literature DB >> 31058179 |
Hanna Song1, Michael DeSantis1, Chunjuan Tian1, Wei Cheng1.
Abstract
The route of HIV-1 entry for productive infection in CD4+ host cells is a fundamental question for the molecular understanding of HIV-1 infection and transmission. Although direct fusion has long been thought to be the mode of entry, recent studies have suggested that productive entry of HIV-1 may actually occur through dynamin-dependent endocytosis. In several of these studies, dynasore, a noncompetitive inhibitor of the GTPase activity of dynamin, has been used to support this conclusion. Here we show that dynasore does produce inhibitory effects on the productive infection of HIV-1 in several commonly used cell lines. This effect is present regardless of the methods used to facilitate the infection of HIV-1. However, transferrin uptake remains fully functional in these cell lines upon dynasore treatment. Therefore, the inhibition on HIV-1 infection by dynasore in these cell lines is due to an effect that is independent of transferrin endocytosis. The use of dynasore in probing the role of endocytosis in HIV-1 infection should be corroborated by other methods.Entities:
Keywords: Biochemistry; Biophysics; Cell Biology; Dynasore; Endocytosis; HIV
Year: 2018 PMID: 31058179 PMCID: PMC6492620 DOI: 10.19185/matters.201805000001
Source DB: PubMed Journal: Matters (Zur) ISSN: 2297-8240
Figure 1.Effects of dynasore on HIV-1 infection and transferrin endocytosis in cell culture.
(A) Inhibition of productive HIV-1 infection by dynasore or T20 in TZM-bl, Rev-CEM, and SUP-T1 cell lines. The fractions of remaining HIV-1 infectivity (diamonds) or fractions of live cells (white bars) upon dynasore treatment is shown in (a), (c) and (e) for TZM-bl, Rev-CEM and SUP-T1 cells, respectively. The fractions of remaining HIV-1 infectivity or fractions of live cells upon T20 treatment is shown in (b), (d) and (f) for TZM-bl, Rev-CEM and SUP-T1 cells, respectively. All the infectivity values were normalized to the infectivity measured in each cell line in the absence of dynasore or T20 treatment. Error bars represent standard deviations from 3 independent repeats of the same experiments.
(B) Inhibition of productive HIV-1 infection in TZM-bl cells by dynasore under various conditions. (a) The fractions of remaining infectivity for HIV-1 NL4–3 virions (filled circles) or HIV-1 pseudotyped with VSV-G (hollow squares) upon treatment of the cells with various concentrations of dynasore. 20 μg/ml DEAE-dextran was included in the incubation mixture. (b) The fractions of remaining infectivity for HIV-1 NL4–3 virions in the absence of DEAE-dextran (hollow circles) or presence of 20 μg/ml DEAE-dextran (filled circles) upon treatment of the cells with various concentrations of dynasore. (c) The fractions of remaining infectivity for various HIV-1 virions in the presence of 20 μg/ml DEAE-dextran (Dextran), or in the absence of DEAE-dextran but under spinoculation (Spin). All cells were pretreated with 80 μM dynasore for 30 min at 37°C. NL4–3: NL4–3 virions with NL4–3 envelope glycoproteins; HXB2: NL4–3 virions pseudotyped with HXB2 envelope glycoproteins. Error bars represent standard deviations from 3 independent repeats of the same experiments.
(C) Measurement of inhibition on transferrin uptake by dynasore in TZM-bl, Rev-CEM, and SUP-T1 cell lines. The percentages of Alexa-488 positive cells upon incubation with Aelxa-488 conjugated transferrin at 37°C for 5 min (white bars) or at 4°C throughout (black bars) is shown in (a), (b) and (c) for TZM-bl, Rev-CEM and SUP-T1 cells, respectively. All cells were pretreated with dynasore at various concentrations as indicated for 30 min at 37°C. All the percentages were normalized to the cell number measured in each cell line in the absence of dynasore treatment at 37°C. Error bars represent standard deviations from 2 independent repeats of the same experiments.
(D)Confocal images of TZM-bl cells upon uptake of Alexa-488 conjugated transferrin in the absence of dynasore (a) or after treatment with 200 μM dynasore (b).